国产人人色I色婷婷综合久久中文字幕雪峰I奇米色777欧美一区二区I久热久热aV爽青青在线I国产av喷水I国产伦精品一区二区三区免.费I高潮av在线Iww欧美一级I91天天看I黄a在线91I九一无码中文字幕久久无码色…I丰满国产精品视频二区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / HK Macao

HKSAR LegCo passes funding application to assist industries affected by COVID-19 pandemic

Xinhua | Updated: 2022-04-13 09:04
Share
Share - WeChat
Hong Kong Chief Executive Carrie Lam Cheng Yuet-ngor (center) visits Hong Kong Baptist University's Chinese Medicine Telemedicine Centre Against COVID-19 on March 12. [Photo provided to China Daily]

HONG KONG -- Chief Executive of the Hong Kong Special Administrative Region Carrie Lam on Tuesday welcomed the passage of the government's funding application by the Finance Committee of the Legislative Council (LegCo) for an injection of 43 billion Hong Kong dollars ($5.49 billion) into the anti-epidemic fund to implement the 2022 Employment Support Scheme.

Lam said in an online statement that the new round of ESS aims to provide three-month wage subsidies from May to July for industries directly or indirectly affected by the fifth wave of the pandemic in Hong Kong, especially the small and medium enterprises.

The HKSAR government estimated that the refined ESS will benefit around 160,000 employers, 1.6 million employees and 140,000 self-employed persons.

Lam said a simple and convenient application procedure would be the guiding principle in implementing the ESS. The scheme aims to be open for application later this month, with a view to grant financial assistance to the first batch of successful applicants in early May.

She believed that the 2022 ESS, together with the measures rolled out earlier in the fifth and sixth rounds of the anti-epidemic fund worth a total of 30.6 billion Hong Kong dollars, as well as the wide range of relief measures in the 2022-23 budget, will accelerate the rebound of the local economy upon the subsiding of the fifth wave of the pandemic.

On Tuesday, Hong Kong registered 735 new COVID-19 cases by nucleic acid tests, and 698 additional positive cases through self-reported rapid antigen tests, official data showed.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US